ARCHIVES

FDA Advisors: DepoCyt May Test Accelerated Approval Mechanism

This article is from The Cancer Letter archive.

Vol. 24 No. 45 | November 27, 1998

Download PDF Visit The Full Archive

Related Articles

Shubick Committee Support New System for NCU Review, Action On Chemicals

November 14, 1975

ASCO Urges Increase In NIH, NCI Budgets.

January 25, 2008

DCT Board Approves Concepts For New RFA, New And Recompeting Contracts

June 18, 1982

Two cancer center directors named: Michael Kastan at St. Jude, James Willson at Harold Simmons.

December 10, 2004

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

September 30, 2005

Human Genome Project publishes its final product.

October 22, 2004